First Study of Oral Artenimol-R in Advanced Cervical Cancer: Clinical Benefit, Tolerability and Tumor Markers - 0 views
-
Nathan Goodyear on 13 Jun 19Results show a clear down-regulation of p53, EGFR, Ki-67 and CD31 in cervical cancer cells.